PRELUDE CAPITAL MANAGEMENT, LLC - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 4 filers reported holding SYNERON MEDICAL LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 23.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q2 2017$1,258,000
+364.2%
114,926
+346.6%
0.12%
+357.7%
Q1 2017$271,000
-8.1%
25,731
-26.7%
0.03%
-27.8%
Q4 2016$295,000
+656.4%
35,112
+550.2%
0.04%
+800.0%
Q3 2016$39,000
+18.2%
5,400
+25.6%
0.00%
-20.0%
Q2 2016$33,000
+83.3%
4,300
+73.0%
0.01%
+66.7%
Q1 2016$18,000
-60.0%
2,486
-31.2%
0.00%
-50.0%
Q1 2015$45,0003,6160.01%
Other shareholders
SYNERON MEDICAL LTD shareholders Q3 2017
NameSharesValueWeighting ↓
HealthInvest Partners AB 706,107$5,931,0005.46%
NORTH TIDE CAPITAL, LLC 3,500,000$29,400,0005.03%
Senvest Management, LLC 3,777,775$31,733,0002.26%
Kenmare Capital Partners, L.L.C. 269,839$2,267,0001.72%
Camber Capital Management LP 2,347,593$19,720,0001.03%
DALTON GREINER HARTMAN MAHER & CO 1,785,826$15,001,0000.88%
PERRITT CAPITAL MANAGEMENT INC 425,170$3,571,0000.87%
Profit Investment Management, LLC 88,777$746,0000.70%
DAFNA Capital Management LLC 85,947$722,0000.63%
Lapides Asset Management, LLC 396,800$3,333,0000.60%
View complete list of SYNERON MEDICAL LTD shareholders